Lipofen Capsule
Product Images NDC 62559-306

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lipofen (NDC 62559-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lipofen 01)

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Principal Display Panel (50 mg Capsule Bottle Label)
This text provides information about a medication called "fenofibrate capsules, USP". Each capsule contains 50 mg of LI ofen@fenofbrate, USP. The text includes the dosage and usage information, and refers the reader to the package insert for full prescribing information. It also includes storage instructions and the distributor information.*
FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Principal Display Panel (150 mg Capsule Bottle Label)
Dosage and usage information for Lipofen fenofibrate capsules, USP containing 150 mg per capsule can be found in the package insert. The capsules should be stored at controlled room temperature, between 15°C - 30°C (59°F - B6%F) to prevent excursions. Moisture and light should also be avoided to protect the product. Distributed by NI Pharmaceuticals, Inc., the product is made in Israel and the NDC number is 62559-306-90. This is a prescription drug.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.